This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: University of Cape Town, Mmv Medicines for Malaria Venture. Active years: 2011-2019.
Company Filing History:
4 out of 94 
1 out of 11 Years Active: 2011-2019
Title: The Innovative Contributions of Kelly Chibale
Introduction
Kelly Chibale is a prominent inventor based in Claremont, South Africa. She has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-malarial agents. With a total of four patents to her name, Chibale's work is focused on combating malaria, a disease that continues to affect millions worldwide.
Latest Patents
Chibale's latest patents revolve around the use of aminopyrazine derivatives in the manufacture of medicaments for preventing or treating malaria. Specifically, these inventions relate to aminopyrazine derivatives that are useful for the preparation of pharmaceutical formulations aimed at inhibiting the proliferation of malaria parasites. The innovative approach she has taken in her research highlights the potential of these compounds in the fight against malaria.
Career Highlights
Throughout her career, Kelly Chibale has been associated with esteemed institutions such as the University of Cape Town and Medicines for Malaria Venture. Her work in these organizations has allowed her to advance her research and contribute to the development of effective treatments for malaria.
Collaborations
Chibale has collaborated with notable colleagues, including David Waterson and Michael John Witty. These partnerships have played a crucial role in enhancing her research and expanding the impact of her inventions.
Conclusion
Kelly Chibale's innovative work in the field of anti-malarial agents showcases her dedication to improving global health. Her contributions through patents and collaborations reflect her commitment to finding solutions for one of the world's most pressing health challenges.